Katherine A. Sanders
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells
Sanders, Katherine A.; Benton, Miles C.; Lea, Rod A.; Maltby, Vicki E.; Agland, Susan; Griffin, Nathan; Scott, Rodney J.; Tajouri, Lotti; Lechner-Scott, Jeannette
Authors
Miles C. Benton
Rod A. Lea
Vicki E. Maltby
Susan Agland
Nathan Griffin
Rodney J. Scott
Lotti Tajouri
Jeannette Lechner-Scott
Abstract
Background: Immunoactivation is less evident in secondary progressive MS (SPMS) compared to relapsing-remitting disease. MicroRNA (miRNA) expression is integral to the regulation of gene expression; determining their impact on immune-related cell functions, especially CD4+ T cells, during disease progression will advance our understanding of MS pathophysiology. This study aimed to compare miRNA profiles of CD4+ T cells from SPMS patients to healthy controls (HC) using whole miRNA transcriptome next-generation sequencing (NGS). Total RNA was extracted from CD4+ T cells and miRNA expression patterns analyzed using Illumina-based small-RNA NGS in 12 SPMS and 12 HC samples. Results were validated in a further cohort of 12 SPMS and 10 HC by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results: The ten most dysregulated miRNAs identified by NGS were selected for qPCR confirmation; five (miR-21-5p, miR-26b-5p, miR-29b-3p, miR-142-3p, and miR-155-5p) were confirmed to be down-regulated in SPMS (p < 0.05). SOCS6 is targeted by eight of these ten miRNAs. Consistent with this, SOCS6 expression is up-regulated in SPMS CD4+ T cells (p < 0.05). This is of particular interest as SOCS6 has previously been shown to act as a negative regulator of T cell activation. Conclusions: Ninety-seven percent of miRNA candidates identified by NGS were down-regulated in SPMS. The down-regulation of miRNAs and increased expression of SOCS6 in SPMS CD4+ T cells may contribute to reduced immune system activity in progressive MS.
Citation
Sanders, K. A., Benton, M. C., Lea, R. A., Maltby, V. E., Agland, S., Griffin, N., Scott, R. J., Tajouri, L., & Lechner-Scott, J. (2016). Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells. Clinical epigenetics, 8(1), Article 87. https://doi.org/10.1186/s13148-016-0253-y
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 9, 2016 |
Online Publication Date | Aug 27, 2016 |
Publication Date | Aug 27, 2016 |
Deposit Date | Aug 23, 2023 |
Publicly Available Date | Sep 27, 2023 |
Journal | Clinical Epigenetics |
Print ISSN | 1868-7075 |
Electronic ISSN | 1868-7083 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 8 |
Issue | 1 |
Article Number | 87 |
DOI | https://doi.org/10.1186/s13148-016-0253-y |
Keywords | Multiple sclerosis; Secondary progressive; MicroRNAs; Immunology; CD4+ T cells; Next-generation sequencing |
Public URL | https://hull-repository.worktribe.com/output/4366618 |
Publisher URL | https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-016-0253-y |
Files
Published article
(729 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0
Copyright Statement
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
You might also like
Personal autonomy and self-determination are crucial for professionalism in healthcare
(2023)
Journal Article